Posted in | News | Control Systems

TowerJazz Increases Production of N-trig-Developed Touch Screen Controller for Digital Pen

TowerJazz, the global specialty foundry leader, today announced it is ramping high volume production of a touch screen controller developed by N-trig, an Israeli company.

Recently, this advanced digital pen technology was acquired by Microsoft for use with its Surface products. The touch screen controller, which enables special capabilities of sensing multi-fingers touch and a digital pen (stylus), will be produced using TowerJazz's advanced 0.18-micron power management process (TS18PM). N-trig's ICs were designed by N-trig with the support of TowerJazz's Netanya Design Center (NDC) in Israel and are being manufactured in its Migdal Haemek, Israel fabrication facility (Fab 2).

"Mass producing N-trig technology for an industry giant further enhances our position as a leading power management IC manufacturer. N-trig chose to work with TowerJazz due to our excellent design and engineering support as well as our platform capability. We look forward to supporting further innovation for these products and providing volume production as the tablet market continues to grow," said Russell Ellwanger, TowerJazz Chief Executive Officer.

TowerJazz offers an industry leading Bipolar-CMOS-DMOS (BCD) power management process used in consumer, communications and computing applications. The foundry's customizable LDMOS (20V to 80V) process platform provides design optimization and the lowest die size at any given breakdown voltage. The platform offers maximum flexibility, enabling customers to create cost-effective products at any desired level of integration and achieve first-pass success for faster time-to-market. For enhanced power management solutions, TowerJazz offers Non-Volatile Memory (NVM) and a groundbreaking 700V power platform that is unrivaled by other foundries.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.